Mice experiencing transient or permanent cerebral ischemia have reduced infarct size and more preserved neurological function by knocking down iNOS gene expression or using NOS inhibitors (47, 48).Therefore, RNS may be a therapeutic target for the treatment of post-stroke ischemic injury. This evidence concerns the gene NOS2 and Cerebral ischemia.